Tracer library / [18F]VM4-037
Structure of VM4-037 (unlabelled parent compound, from PubChem)
Unlabelled parent compoundPubChem CID 59552698

[18F]VM4-037

Also written as [18F]VM4-037; [F-18]VM4-037; VM4-037
Radionuclide
F-18 t½ 109.7 min
Modality
PET
Production route
Cyclotron liquid target
Stage
Research
Syntheses indexed
0

What it is

Compound class
Sulfonamide
Target / mechanism
Carbonic anhydrase IX (CAIX) PMID 24696183 / DOI 10.1007/s11307-014-0730-7; PMID 25708744 / DOI 10.1007/s11307-015-0831-y
Clinical application
PET imaging of carbonic anhydrase IX (CAIX) expression in tumours (studied in renal cell carcinoma; high liver/kidney background limits use) PMID 24696183 / DOI 10.1007/s11307-014-0730-7; PMID 25708744 / DOI 10.1007/s11307-015-0831-y
Theranostic pair
—

Regulatory status

FDA
No Drugs@FDA / openFDA drug registry — no approved application found; search: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process&searchTerm=VM4-037
EMA (centralised)
—
Other approvals
—
Brand names
—

Clinical use

Typical injected activity
584 +/- 143 MBq (range 401-728 MBq) PMID 24696183 / DOI 10.1007/s11307-014-0730-7
Uptake time
Whole-body PET series ~11-133 min post-injection (~1 h data used) PMID 24696183 / DOI 10.1007/s11307-014-0730-7

Reported in the literature. Not a dosing recommendation.

Published syntheses

No synthesis has been parsed for this agent yet.

Precursor

Common precursor
VM4-037 precursor 1 (nucleophilic [18F]fluorination in acetonitrile) PMID 24696183 / DOI 10.1007/s11307-014-0730-7
Suppliers seen in the literature
—
Typical final purification
HPLC

Need this precursor?We can point you to suppliers for [18F]VM4-037, or handle the enquiry for you.

Get in touch

Quality control Preliminary - inferred from compound class

Ph. Eur. monograph
not verified No Ph. Eur. check is recorded for this entry.
USP monograph
not verified No USP check is recorded for this entry.
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]VM4-037.

Get in touch
Ask a question